We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity.
- Authors
Guoqiang Zhong; Chengcheng He; Shanping Wang; Chuangzhen Lin; Mingsong Li
- Abstract
Inflammatory bowel disease (IBD), a general term encompassing Crohn’s disease (CD) and ulcerative colitis (UC), and other conditions, is a chronic and relapsing autoimmune disease that can occur in any part of the digestive tract. While the cause of IBD remains unclear, it is acknowledged that the disease has much to do with the dysregulation of intestinal immunity. In the intestinal immune regulatory system, Cholesterol-25-hydroxylase (CH25H) plays an important role in regulating the function of immune cells and lipid metabolism through catalyzing the oxidation of cholesterol into 25-hydroxycholesterol (25-HC). Specifically, CH25H focuses its mechanism of regulating the inflammatory response, signal transduction and cell migration on various types of immune cells by binding to relevant receptors, and the mechanism of regulating lipid metabolism and immune cell function via the transcription factor Sterol Regulator-Binding Protein. Based on this foundation, this article will review the function of CH25H in intestinal immunity, aiming to provide evidence for supporting the discovery of early diagnostic and treatment targets for IBD.
- Subjects
CROHN'S disease; INFLAMMATORY bowel diseases; HYDROXYCHOLESTEROLS; INTESTINES; ULCERATIVE colitis; ERGOSTEROL; LIPID metabolism
- Publication
Frontiers in Immunology, 2023, p1
- ISSN
1664-3224
- Publication type
Article
- DOI
10.3389/fimmu.2023.1241262